Medication info
Albit Tablet

Albit Tablet

Prescription medicationTabletOralExpired
Ingredient · strength
Ranitidine Hydrochloride›84mg / 1 tabletTripotassium Bismuth Dicitrate›100mg / 1 tabletSucralfate Hydrate›300mg / 1 tablet
Manufacturer / importer
Korea PMG Pharmaceutical Co., Ltd.
Appearance
Round white film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Expired

MFDS item code 201405006 · Approved 2014.10.29

This product's status changed to Expired on 2024.10.29. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related disorders (ulcers, gastritis, gastroesophageal reflux disease, etc.) and prevention of Mendelson's syndrome
Who takes it
Adults
Adult dose
○ Adults Usually, administer 2 tablets per dose orally 2 times daily, regardless of meals, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 2 tablets per dose 2 times daily, or 4 tablets per dose once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 4 tablets per dose 2 times daily, in the morning and at bedtime. The same dose applies to combination therapy for ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term treatment with nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 4 weeks, and ulcers usually heal within 8 weeks, although healing may take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets per dose once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 2 tablets per dose 2 times daily for 8 weeks, or 4 tablets per dose once daily at bedtime. However, the dose may be increased to 4 tablets per dose 4 times daily for patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 2 tablets per dose 3 times daily, and increase the dose as needed. For severe disease, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 2 tablets per dose 2 times daily. 5) Premedication before anesthesia (prevention of Mendelson's syndrome) Administer 2 tablets per dose 2 hours before induction of anesthesia. In this case, it is also preferable to administer 2 tablets per dose on the night before surgery.

Ingredients

Manufacturer
Korea PMG Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (ulcers, gastritis, gastroesophageal reflux disease, etc.) and prevention of Mendelson's syndrome

  • Gastric and duodenal ulcers
  • gastritis
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • postoperative ulcers
  • gastric and duodenal ulcers due to NSAIDs.
View approved original text

This medication is used for the treatment of ulcers in the stomach and duodenum, gastritis, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It also helps in the prevention of postoperative ulcers and treats gastric and duodenal ulcers caused by NSAIDs (non-steroidal anti-inflammatory drugs). It is administered before anesthesia to prevent Mendelson's syndrome. This medication regulates gastric acid secretion, protects the gastric mucosa, and is effective in alleviating symptoms. It is widely used for the treatment and prevention of gastrointestinal diseases.

How to take

Adult dose

○ Adults Usually, administer 2 tablets per dose orally 2 times daily, regardless of meals, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer 2 tablets per dose 2 times daily, or 4 tablets per dose once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 4 tablets per dose 2 times daily, in the morning and at bedtime. The same dose applies to combination therapy for ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term treatment with nonsteroidal anti-inflammatory drugs. Conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 4 weeks, and ulcers usually heal within 8 weeks, although healing may take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 2 tablets per dose once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer 2 tablets per dose 2 times daily for 8 weeks, or 4 tablets per dose once daily at bedtime. However, the dose may be increased to 4 tablets per dose 4 times daily for patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 2 tablets per dose 3 times daily, and increase the dose as needed. For severe disease, up to 6 g of ranitidine per day may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 2 tablets per dose 2 times daily. 5) Premedication before anesthesia (prevention of Mendelson's syndrome) Administer 2 tablets per dose 2 hours before induction of anesthesia. In this case, it is also preferable to administer 2 tablets per dose on the night before surgery.

Precautions

This medication should not be used in patients undergoing dialysis or those with impaired kidney function. Additionally, patients who have had allergic reactions to this medication or its ingredients, those with a history of acute porphyria, patients who have had upper gastrointestinal surgery, pregnant women or women who may become pregnant, premature infants or neonates, and patients on a potassium-restricted diet should also avoid it. Patients with poor liver function, those who have previously had drug allergies, elderly patients, those with kidney problems, and those taking NSAIDs should use this medication cautiously. Particularly, this medication can mask symptoms of gastric cancer, so patients with gastric ulcers or those over middle age who have recently developed dyspepsia should use it only after confirming the malignancy. Patients with Helicobacter pylori in gastric or duodenal ulcers should receive eradication therapy simultaneously, and severe patients in intensive care, patients with hypophosphatemia, and those who have difficulty swallowing also need to exercise caution. Rarely, serious allergic reactions such as anaphylactic shock may occur while using this medication, so if symptoms arise, administration should be stopped immediately and appropriate treatment sought. Hypersensitivity reactions such as skin rash, hives, angioedema, fever, and bronchospasm may also occur, and if these symptoms appear, the medication should be discontinued. Regular testing is required as blood tests may show decreased white blood cells, platelets, or liver function abnormalities. Gastrointestinal symptoms may include nausea, vomiting, constipation, diarrhea, and abdominal pain, and the stool may turn black, although this does not require special treatment. In severe and elderly patients, dizziness, drowsiness, confusion, depression, and hallucinations may occur infrequently, so caution is advised. Myalgia or arthralgia may occur, and in severe cases, rhabdomyolysis can occur, so if there are any unusual symptoms, medical personnel should be informed immediately. This medication should not be taken long-term and should be used in the minimum dose while carefully monitoring the treatment process. Elderly patients or those with chronic pulmonary diseases or diabetes may have an increased risk of pneumonia while taking this medication. If dizziness or drowsiness occurs while taking this medication, driving or operating hazardous machinery should be avoided. There may be interactions with other medications, so especially when taking anticoagulants or certain antibiotics or analgesics, consultation with healthcare providers is essential. It is safest for pregnant or breastfeeding women not to use this medication, and safety in children has not been established, so it is not recommended for pediatric use. In case of overdose, treatments such as vomiting or gastric lavage may be necessary, and in severe cases, blood dialysis may be helpful. Finally, this medication can reduce gastric acid secretion and promote bacterial growth in the stomach, so regular check-ups, including eye examinations, are necessary for long-term use.

Side effects

  • Anaphylactic shock
  • skin rash
  • hives
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • leukopenia
Show 56 more
  • thrombocytopenia
  • elevated serum creatinine
  • elevated serum aminotransferases
  • agranulocytosis
  • pancytopenia
  • myelodysplasia
  • aplastic anemia
  • acquired immune hemolytic anemia
  • eosinophilia
  • elevated AST
  • elevated ALT
  • elevated r-GTP
  • elevated ALP
  • jaundice hepatitis
  • non-jaundice hepatitis
  • tachycardia
  • bradycardia
  • heart block
  • premature ventricular contractions
  • arrhythmia
  • vasculitis
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • dizziness
  • drowsiness
  • confusional state
  • convulsions
  • agitation
  • insomnia
  • headache
  • heaviness in the head
  • sense of illness
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorders
  • consciousness disorders
  • hepatic muscle spasms
  • gynecomastia
  • excessive milk secretion
  • erectile dysfunction
  • decreased libido
  • joint pain
  • muscle pain
  • rhabdomyolysis
  • hair loss
  • glossitis
  • skin itching
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air ingress, and it is best stored at room temperature between 1 to 30 degrees Celsius. Storing it this way will help maintain the effectiveness of the medication and prevent degradation.

Appearance and packaging

Appearance

Round white film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.